Standout Papers

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients Wit... 2000 2026 2008 2017 923
  1. Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma (2000)
    Mark R. Middleton, Jean‐Jacques Grob et al. Journal of Clinical Oncology

Immediate Impact

29 by Nobel laureates 6 from Science/Nature 99 standout
Sub-graph 1 of 20

Citing Papers

Cutaneous melanoma
2023 Standout
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
35 intermediate papers

Works of Steinar Aamdal being referenced

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
2016
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
2013
and 12 more

Author Peers

Author Last Decade Papers Cites
Steinar Aamdal 4048 2313 2938 130 6.5k
René González 6499 2587 4272 188 9.0k
Paola Queirolo 5242 2450 2947 229 7.1k
Ferdy J. Lejeune 3233 3216 2626 119 7.2k
Emina H. Huang 4056 1953 2677 108 7.2k
Gabriel Sica 3884 2916 1914 96 6.7k
Sanjiv S. Agarwala 6012 2440 4167 205 9.5k
Pier Francesco Ferrucci 3616 1631 2889 139 6.1k
Ahmad A. Tarhini 5490 3538 2374 272 7.8k
Scot Ebbinghaus 3911 1635 2734 96 6.5k
Filip Lardon 2630 1506 2803 164 6.2k

All Works

Loading papers...

Rankless by CCL
2026